[go: up one dir, main page]

WO2011061761A3 - Composition pharmaceutique à usage parentéral - Google Patents

Composition pharmaceutique à usage parentéral Download PDF

Info

Publication number
WO2011061761A3
WO2011061761A3 PCT/IN2010/000745 IN2010000745W WO2011061761A3 WO 2011061761 A3 WO2011061761 A3 WO 2011061761A3 IN 2010000745 W IN2010000745 W IN 2010000745W WO 2011061761 A3 WO2011061761 A3 WO 2011061761A3
Authority
WO
WIPO (PCT)
Prior art keywords
mycophenolate mofetil
pharmaceutical composition
parenteral use
pharmaceutical compositions
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2010/000745
Other languages
English (en)
Other versions
WO2011061761A2 (fr
Inventor
Vj. Pakalapati Ramani
Nagaraj Amminabavi
Subhash Gore
Manoj Pananchukunnath
Rajesh Gupta
Indu Bhushan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Laboratories Ltd
Original Assignee
Matrix Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Laboratories Ltd filed Critical Matrix Laboratories Ltd
Publication of WO2011061761A2 publication Critical patent/WO2011061761A2/fr
Anticipated expiration legal-status Critical
Publication of WO2011061761A3 publication Critical patent/WO2011061761A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques comprenant un immunosuppresseur et destinées à l'administration parentérale. Plus particulièrement, l'invention concerne des compositions pharmaceutiques destinées à l'administration parentérale et comprenant le mycophénolate mofétil ou un sel pharmaceutiquement acceptable de celui-ci.
PCT/IN2010/000745 2009-11-17 2010-11-16 Composition pharmaceutique à usage parentéral Ceased WO2011061761A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2821CH2009 2009-11-17
IN2821/CHE/2009 2009-11-17

Publications (2)

Publication Number Publication Date
WO2011061761A2 WO2011061761A2 (fr) 2011-05-26
WO2011061761A3 true WO2011061761A3 (fr) 2013-04-25

Family

ID=44060142

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000745 Ceased WO2011061761A2 (fr) 2009-11-17 2010-11-16 Composition pharmaceutique à usage parentéral

Country Status (1)

Country Link
WO (1) WO2011061761A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106943359B (zh) * 2016-01-06 2020-05-01 山东新时代药业有限公司 一种稳定的注射用吗替麦考酚酯及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087174A1 (fr) * 2003-04-01 2004-10-14 Novartis Ag Formulation parenterale

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087174A1 (fr) * 2003-04-01 2004-10-14 Novartis Ag Formulation parenterale

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RXLIST THE INTERNET DRUG INDEX: "CellCept", 29 June 2012 (2012-06-29), XP002692430, Retrieved from the Internet <URL:http://www.rxlist.com/script/main/rxlist.asp?articlekey=66621&pf=3&page=1> [retrieved on 20130219] *

Also Published As

Publication number Publication date
WO2011061761A2 (fr) 2011-05-26

Similar Documents

Publication Publication Date Title
WO2010036407A3 (fr) Analogues nucléosidiques antiviraux
WO2007086001A3 (fr) Nouveaux dérivés de pyridine
WO2009111653A3 (fr) Agents thérapeutiques antiviraux
MY154909A (en) Novel thiophene derivatives
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
WO2010092090A3 (fr) Nouveaux sels de la sitagliptine
WO2012021715A3 (fr) Formulations stables de linaclotide
WO2009135646A3 (fr) Compositions pharmaceutiques stables et procédés de préparation desdites compositions adaptés à l’échelle industrielle
WO2008057550A3 (fr) Stabilisation de vaccins par lyophilisation
WO2007150025A3 (fr) Dérivés de purinone en tant qu&#39;agonistes du hm74a
WO2011009938A3 (fr) Stambomycine et dérivés, leur production et leur utilisation comme médicaments
WO2011157722A3 (fr) Composition contenant de l&#39;ivabradine solide
EA201300990A1 (ru) Парентеральное введение тапентадола
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2012106665A3 (fr) Disialyllacto-n-tétraose (dslnt) ou variants, isomères, analogues et dérivés associés, pour prévenir ou inhiber une maladie intestinale
WO2013080217A3 (fr) Formes cristallines de carbazitaxel et leur procédé de préparation
WO2010049449A3 (fr) Nouveaux sels de sunitinib
WO2011122872A3 (fr) Composition comprenant du coumestrol ou un extrait de fèves contenant du coumestrol
WO2009071650A3 (fr) Composés amidés comme renforçateurs de médicaments antiviraux
WO2009115084A3 (fr) Nouveaux dérivés de pyrrolopyrimidine et leurs utilisations
WO2008001201A3 (fr) Compositions pharmaceutiques de clopidogrel
WO2012137227A3 (fr) Formes solides de composés antirétroviraux, procédé de préparation correspondant et composition pharmaceutique de ces composés
WO2008088779A3 (fr) Formes solides de 5-azacytidine et procédés de préparation de ces dernières
WO2011135580A3 (fr) Compositions pharmaceutiques de sirolimus
WO2008137134A3 (fr) Bromhydrate d&#39;élétriptan amorphe et son procédé de préparation, et autres formes de bromhydrate d&#39;élétriptan

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10831265

Country of ref document: EP

Kind code of ref document: A2